Madison, WI (August 2012) — In the first year of eligibility, Quincy Bioscience has been included in the Inc. 500 list of fastest growing private companies in the United States, and has been ranked at No. 398. Quincy Bioscience is a biotechnology company based in Madison, Wis. that’s committed to improving cognitive health in the aging population.
In 2007, Quincy Bioscience introduced the brain health supplement Prevagen® for clearer thinking. Prevagen contains the patented compound apoaequorin — a first-in-class technology which has proven effective at improving brain cell survival and increasing domains of cognitive function such as executive function, short-term memory, and word recall.
Quincy Bioscience would like to thank staff, clinical trial participants, and the many supporters that have made the incredible growth of the company possible.
“The privilege of being ranked in the Inc. 500 list is a testament to the value of apoaequorin research for preventative neurological care,” said Mark Underwood, president and co-founder of Quincy Bioscience. “Apoaequorin has proven that it is capable of changing the lives of millions of Americans. We are honored to continue working towards the goal of better and healthier brains for people worldwide.”
In 1982, Inc. introduced the Inc. 500 list of the fastest-growing privately held companies in the United States. Today, the list is a distinguished editorial award, a celebration of innovation, and a network of entrepreneurial leaders. The Inc. 500|5000 ranks companies by overall revenue growth over a three-year period.